Full Text
The Full Text of this article is available as a PDF (50.2 KB).
editorial . 2013 Jul 25;13(3):131–132. doi: 10.3233/CBM-130333
Adrenergic signaling and cancer: Deciphering the connections
Amal Melhem-Bertrandt
a,b,*, Anil K Sood
c,d
Amal Melhem-Bertrandt
aDepartment of Breast medical Oncology, M.D. Anderson Cancer Center, Houston, TX, USA
bBreast Cancer Survivorship Clinic, M.D. Anderson Cancer Center, Houston, TX, USA
Find articles by Amal Melhem-Bertrandt
Anil K Sood
cDepartment of Gynecologic Oncology and Cancer Biology, M.D. Anderson Cancer Center, Houston, TX, USA
dCenter for RNA Interference and Non-Coding RNA, M.D. Anderson Cancer Center, Houston, TX, USA
Find articles by Anil K Sood
Editors: Amal Melhem-Bertrandtx, Anil K Soody
xDepartment of Breast medical Oncology, M.D. Anderson Cancer Center, Houston, TX, USA
yDepartment of Gynecologic Oncology, M.D. Anderson Cancer Center, Houston, TX, USA
aDepartment of Breast medical Oncology, M.D. Anderson Cancer Center, Houston, TX, USA
bBreast Cancer Survivorship Clinic, M.D. Anderson Cancer Center, Houston, TX, USA
cDepartment of Gynecologic Oncology and Cancer Biology, M.D. Anderson Cancer Center, Houston, TX, USA
dCenter for RNA Interference and Non-Coding RNA, M.D. Anderson Cancer Center, Houston, TX, USA
*
Corresponding author: Amal Melhem-Bertrandt, Department of Breast medical Oncology, M.D. Anderson Cancer Center, 1155 Herman Pressler Unit 1354, Houston, TX 77030, USA. Tel.: +1 713 792 2817; Fax: +1 713 794 4385; E-mail: amelhem@mdanderson.org.
Collection date 2013.
IOS Press and the authors. All rights reserved
This is a free to read article. Copyright IOS Press and the authors.
PMCID: PMC12928268 PMID: 23912484